Deletion of IP-10 in fibrosis-associated HCC mice leads to the enhancement of anti-tumoral immune cells and an overall reduction of chemokines, but to a specific accumulation of chemokines at the tumor site [31,32]. This evidence concerns the gene CXCL10 and hepatocellular carcinoma.